The July Kaiser Health Tracking Poll finds that over half the public has an unfavorable view of the Affordable Care Act (ACA) in July, up eight percentage points since last month, while the share viewing the law favorably held steady at just under four in ten. This month’s poll also explored the public’s reaction to the Supreme Court decision upholding craft store chain Hobby Lobby’s ability to deny workers coverage of certain contraceptives based on the company’s owners’ religious beliefs. The public overall is evenly split between those who approve and disapprove of the Court’s decision, with only a small difference in opinion between women and men, but deep divisions by party identification, ideology, and religious affiliation.
- view as grid
- view as list
The Supreme Court is expected to reach a decision by the end of June, 2014 on the cases brought forth by Hobby Lobby and Conestoga Wood Specialties, two for profit corporations challenging the ACA’s contraceptive coverage requirement. The plaintiffs contend that the requirement that they include coverage for certain contraceptive services (emergency contraceptive pills and intrauterine devices) in the insurance plans “substantially burdens” both the corporation’s and the owners’ religious rights. During the arguments, several of the justices discussed the extent to which the corporations did or not did not have a choice in offering coverage to their workers. In this brief, we explore some of the factors influencing coverage decisions and possible consequences for women and employers given possible Supreme Court decision options: either upholding the contraceptive coverage requirement, or in favor of Hobby Lobby.
This report maps the network of international assistance to support family planning and reproductive health in countries around the globe. The report is part of a series that examines the donor nations and multilateral organizations involved in addressing different global health challenges in recipient countries worldwide.
The Affordable Care Act’s contraceptive coverage provision made access to the full range of contraceptive methods available to millions of women with private insurance at no cost. Despite broad public support, this provision has been challenged by religious employers, with two cases reaching the Supreme Court. It is unclear how…
This fact sheet examines the U.S. government’s role in family planning and reproductive health (FP/RH) worldwide.
Donor Government Funding for Family Planning was Essentially Flat in 2015 in Real Terms, Though It Declined When Measured in Current U.S. Dollars
A new Kaiser Family Foundation report finds that donor governments provided US$1.3 billion in bilateral funding for family planning programs in low- and middle-income countries in 2015, essentially matching 2014 levels in real terms (after accounting for exchange rate fluctuations and inflation). In current U.S. dollars, however, 2015 funding was…
In this post, we answer some of the key questions about the new contraceptive coverage policy generally, and more specifically, how it will be applied to religious organizations.
This fact sheet reviews current national and state policies around Emergency Contraception, including methods, patient awareness, access and availability, and insurance coverage. Among methods discussed are ulipristal acetate (including ella), copper IUDs (including Copper-T IUDs), and progestin-based pills (including Plan B, Next Choice,Levonorgestrel and Fallback Solo).
This April 2010 webcast features a discussion of issues and challenges for the Obama Administration’s Global Health Initiative and features three senior-level officials involved in the initiative, as well as outside perspectives of the challenges it faces.
Ask KFF: Alina Salganicoff Answers 3 Questions on Final Title X Regulations for Family Planning Clinics
In light of the new final rule regarding use of Title X federal funds for family planning clinics, Alina Salganicoff, Vice President and Director of Women’s Health Policy at KFF, answers three questions about their impact on women and the clinics that treat them.